Be Ready When Your Crohn's Disease Patients Start Biologics
You'll see biologics considered earlier for Crohn's disease...partly due to new guidelines from the Am College of Gastroenterology.
This "top-down" approach is becoming more popular...versus waiting to see if meds such as sulfasalazine, mesalazine, or corticosteroids help.
For Crohn's, anticipate seeing infliximab (Remicade), adalimumab (Humira), ustekinumab (Stelara), vedolizumab (Entyvio), etc. These can lead to faster and longer-lasting remission for some higher-risk patients.